Atum
VC Fund
Newark, United States
Atum is a VC fund in Newark focused on Biotechnology and Life Science. ATUM provides tools & solutions for the life sciences, from gene design & synthesis, to protein and antibody services.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Atum invests in
Stages Atum invests in
Countries Atum invests in
Investment Focus
Industry
- Biotechnology 2 (100%)
- Life Science 1 (50%)
- Therapeutics 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Wheeler Bio
|
Wheeler Bio is a new biomanufacturing company designed to accelerate the translation of therapeutic innovation into clinical impact. Through parallel integration with pre-clinical discovery, Wheeler is democratizing access to comprehensive discovery-to-IND programs with its rapid, high-quality biomanufacturing and portable CMC platform. | $31M / Series A / Oct 04, 2022 | |
Vernal Biosciences
|
Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis. | $21M / Series A / Jun 02, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Atum invest in?
Atum invests primarily in Biotechnology, Life Science and Therapeutics startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Atum last invest?
The most recent investment recorded for Atum closed in Oct 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
